BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2011;53:26-33. [PMID: 21546856 DOI: 10.1097/mpg.0b013e31822200cc] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Heier CR, Zhang A, Nguyen NY, Tully CB, Panigrahi A, Gordish-Dressman H, Pandey SN, Guglieri M, Ryan MM, Clemens PR, Thangarajh M, Webster R, Smith EC, Connolly AM, McDonald CM, Karachunski P, Tulinius M, Harper A, Mah JK, Fiorillo AA, Chen YW, Cooperative International Neuromuscular Research Group Cinrg Investigators. Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy. J Pers Med 2020;10:E236. [PMID: 33228131 DOI: 10.3390/jpm10040236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 McDermott AM, Kerin MJ, Miller N. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies. PLoS One 2013;8:e83718. [PMID: 24391813 DOI: 10.1371/journal.pone.0083718] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
3 Zahm AM, Hand NJ, Tsoucas DM, Le Guen CL, Baldassano RN, Friedman JR. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon. J Crohns Colitis. 2014;8:1108-1117. [PMID: 24613022 DOI: 10.1016/j.crohns.2014.02.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
4 Felli C, Baldassarre A, Masotti A. Intestinal and Circulating MicroRNAs in Coeliac Disease. Int J Mol Sci 2017;18:E1907. [PMID: 28878141 DOI: 10.3390/ijms18091907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cardo LF, Coto E, Ribacoba R, Menéndez M, Moris G, Suárez E, Alvarez V. MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects. J Mol Neurosci 2014;54:830-6. [PMID: 25284245 DOI: 10.1007/s12031-014-0428-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
6 Qu Z, Li W, Fu B. MicroRNAs in autoimmune diseases. Biomed Res Int 2014;2014:527895. [PMID: 24991561 DOI: 10.1155/2014/527895] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
7 Konstantinidis AΟ, Pardali D, Adamama-Moraitou KK, Gazouli M, Dovas CI, Legaki E, Brellou GD, Savvas I, Jergens AE, Rallis TS, Allenspach K. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 2020;16:69. [PMID: 32087719 DOI: 10.1186/s12917-020-02287-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
8 Tan IL, Coutinho de Almeida R, Modderman R, Stachurska A, Dekens J, Barisani D, Meijer CR, Roca M, Martinez-Ojinaga E, Shamir R, Auricchio R, Korponay-Szabó IR, Castillejo G, Szajewska H, Koletzko S, Zhernakova A, Kumar V, Li Y, Visschedijk MC, Weersma RK, Troncone R, Mearin ML, Wijmenga C, Jonkers I, Withoff S. Circulating miRNAs as Potential Biomarkers for Celiac Disease Development. Front Immunol 2021;12:734763. [PMID: 34950132 DOI: 10.3389/fimmu.2021.734763] [Reference Citation Analysis]
9 Xu XM, Zhang HJ. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World J Gastroenterol 2016; 22(7): 2206-2218 [PMID: 26900285 DOI: 10.3748/wjg.v22.i7.2206] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
10 Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18(34): 4629-4634 [PMID: 23002331 DOI: 10.3748/wjg.v18.i34.4629] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
11 Fofanova TY, Petrosino JF, Kellermayer R. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;62:208-19. [PMID: 26308318 DOI: 10.1097/MPG.0000000000000950] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
12 Barnes EL, Burakoff R. New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflamm Bowel Dis 2016;22:2956-65. [PMID: 27763951 DOI: 10.1097/MIB.0000000000000903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
13 Hand NJ, Horner AM, Master ZR, Boateng LA, LeGuen C, Uvaydova M, Friedman JR. MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia. J Pediatr Gastroenterol Nutr 2012;54:186-92. [PMID: 22167021 DOI: 10.1097/MPG.0b013e318244148b] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
14 Kang K, Peng X, Luo J, Gou D. Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling. J Anim Sci Biotechnol 2012;3:4. [PMID: 22958414 DOI: 10.1186/2049-1891-3-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
15 Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res 2021;9:18. [PMID: 33712063 DOI: 10.1186/s40364-021-00272-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Batra SK, Heier CR, Diaz-Calderon L, Tully CB, Fiorillo AA, van den Anker J, Conklin LS. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1597-606. [PMID: 32793975 DOI: 10.1093/ibd/izaa209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Omidbakhsh A, Saeedi M, Khoshnia M, Marjani A, Hakimi S. Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients. Open Biochem J 2018;12:78-86. [PMID: 30069249 DOI: 10.2174/1874091X01812010078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
18 Rekker K, Saare M, Roost AM, Salumets A, Peters M. Circulating microRNA Profile throughout the menstrual cycle. PLoS One. 2013;8:e81166. [PMID: 24244734 DOI: 10.1371/journal.pone.0081166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
19 Wei K, Zhang D, Hong J, Zhang C, Feng X, Huang Y, Liu J, Wu L, Wu H, Ma X. Herb-Partitioned Moxibustion and the miRNAs Related to Crohn's Disease: A Study Based on Rat Models. Evid Based Complement Alternat Med 2015;2015:265238. [PMID: 25810742 DOI: 10.1155/2015/265238] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
20 Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, Hong SH, Yon DK, Lee SW, Kim MS, Wasuwanich P, Karnsakul W, Shin JI, Kronbichler A. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci 2021;17:2112-23. [PMID: 34131410 DOI: 10.7150/ijbs.59904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145:293-308. [PMID: 23751777 DOI: 10.1053/j.gastro.2013.05.050] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
22 Viennois E, Zhao Y, Merlin D. Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine. Inflamm Bowel Dis. 2015;21:2467-2474. [PMID: 25985250 DOI: 10.1097/mib.0000000000000444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Cao B, Zhou X, Ma J, Zhou W, Yang W, Fan D, Hong L. Role of MiRNAs in Inflammatory Bowel Disease. Dig Dis Sci. 2017;62:1426-1438. [PMID: 28391412 DOI: 10.1007/s10620-017-4567-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
24 Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol. 2013;173:250-258. [PMID: 23607522 DOI: 10.1111/cei.12104] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 8.8] [Reference Citation Analysis]
25 Ge Y, Zhao K, Qi Y, Min X, Shi Z, Qi X, Shan Y, Cui L, Zhou M, Wang Y, Wang H, Cui L. Serum microRNA expression profile as a biomarker for the diagnosis of pertussis. Mol Biol Rep 2013;40:1325-32. [PMID: 23073777 DOI: 10.1007/s11033-012-2176-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
26 Cichon C, Sabharwal H, Rüter C, Schmidt MA. MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers. 2014;2:e944446. [PMID: 25610754 DOI: 10.4161/21688362.2014.944446] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
27 Shentova-eneva R, Velikova T. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New? Gastroenterology Insights 2020;11:58-71. [DOI: 10.3390/gastroent11020009] [Reference Citation Analysis]
28 Zhang L, Cheng J, Fan XM. MicroRNAs: New therapeutic targets for intestinal barrier dysfunction. World J Gastroenterol 2014; 20(19): 5818-5825 [PMID: 24914342 DOI: 10.3748/wjg.v20.i19.5818] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
29 Filip R. An Update on the Role of Extracellular Vesicles in the Pathogenesis of Necrotizing Enterocolitis and Inflammatory Bowel Diseases. Cells 2021;10:3202. [PMID: 34831425 DOI: 10.3390/cells10113202] [Reference Citation Analysis]
30 Baldassarre A, Felli C, Prantera G, Masotti A. Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases. Genes (Basel) 2017;8:E234. [PMID: 28925938 DOI: 10.3390/genes8090234] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
31 Gazouli M, Papaconstantinou I, Stamatis K, Vaiopoulou A, Zeglinas C, Vassiliou I, Giokas G, Tzathas C. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results. Dig Dis Sci. 2013;58:2324-2328. [PMID: 23543085 DOI: 10.1007/s10620-013-2640-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
32 Viennois E, Zhao Y, Han MK, Xiao B, Zhang M, Prasad M, Wang L, Merlin D. Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans. Sci Rep 2017;7:2520. [PMID: 28566745 DOI: 10.1038/s41598-017-02782-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
33 Law IK, Pothoulakis C. MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis. RNA Dis 2015;2:e472. [PMID: 26005712 DOI: 10.14800/rd.472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
34 Dong R, Shen Z, Zheng C, Chen G, Zheng S. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia. Sci Rep 2016;6:21084. [PMID: 26879603 DOI: 10.1038/srep21084] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
35 Kang K, Zhang X, Liu H, Wang Z, Zhong J, Huang Z, Peng X, Zeng Y, Wang Y, Yang Y, Luo J, Gou D. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS One 2012;7:e48536. [PMID: 23152780 DOI: 10.1371/journal.pone.0048536] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
36 Fisher K, Lin J. MicroRNA in inflammatory bowel disease: Translational research and clinical implication. World J Gastroenterol 2015; 21(43): 12274-12282 [PMID: 26604636 DOI: 10.3748/wjg.v21.i43.12274] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
37 Nair N, Kumar S, Gongora E, Gupta S. Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem. 2013;376:33-40. [PMID: 23247724 DOI: 10.1007/s11010-012-1546-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
38 Zhernakova A, Withoff S, Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol 2013;9:646-59. [PMID: 23959365 DOI: 10.1038/nrendo.2013.161] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 8.8] [Reference Citation Analysis]
39 Chen P, Zhou G, Lin J, Li L, Zeng Z, Chen M, Zhang S. Serum Biomarkers for Inflammatory Bowel Disease. Front Med (Lausanne). 2020;7:123. [PMID: 32391365 DOI: 10.3389/fmed.2020.00123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
40 Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR. MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis. BMC Immunol. 2015;16:5. [PMID: 25886994 DOI: 10.1186/s12865-015-0069-0] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 12.6] [Reference Citation Analysis]
41 Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. [PMID: 31737035 DOI: 10.3389/fgene.2019.01017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
42 Stiegeler S, Mercurio K, Iancu MA, Corr SC. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Cells 2021;10:3358. [PMID: 34943865 DOI: 10.3390/cells10123358] [Reference Citation Analysis]
43 Jabandziev P, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:985-93. [PMID: 32009179 DOI: 10.1093/ibd/izaa009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
44 Zahm AM, Hand NJ, Boateng LA, Friedman JR. Circulating microRNA is a biomarker of biliary atresia. J Pediatr Gastroenterol Nutr. 2012;55:366-369. [PMID: 22732895 DOI: 10.1097/mpg.0b013e318264e648] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
45 Harris RA, Nagy-Szakal D, Pedersen N, Opekun A, Bronsky J, Munkholm P, Jespersgaard C, Andersen P, Melegh B, Ferry G, Jess T, Kellermayer R. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:2334-41. [PMID: 22467598 DOI: 10.1002/ibd.22956] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
46 Heier CR, Fiorillo AA, Chaisson E, Gordish-Dressman H, Hathout Y, Damsker JM, Hoffman EP, Conklin LS. Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease. Clin Transl Gastroenterol 2016;7:e192. [PMID: 27628422 DOI: 10.1038/ctg.2016.49] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
47 Bermick J, Schaller M. Epigenetic regulation of pediatric and neonatal immune responses. Pediatr Res 2021. [PMID: 34239066 DOI: 10.1038/s41390-021-01630-3] [Reference Citation Analysis]
48 Chen Y, Ge W, Xu L, Qu C, Zhu M, Zhang W, Xiao Y. miR-200b is involved in intestinal fibrosis of Crohn's disease. Int J Mol Med. 2012;29:601-606. [PMID: 22294131 DOI: 10.3892/ijmm.2012.894] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
49 Ramírez-Sánchez AD, Tan IL, Gonera-de Jong BC, Visschedijk MC, Jonkers I, Withoff S. Molecular Biomarkers for Celiac Disease: Past, Present and Future. Int J Mol Sci 2020;21:E8528. [PMID: 33198309 DOI: 10.3390/ijms21228528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Sun L, Han Y, Wang H, Liu H, Liu S, Yang H, Ren X, Fang Y. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis. J Int Med Res 2022;50:3000605221089503. [PMID: 35443818 DOI: 10.1177/03000605221089503] [Reference Citation Analysis]
51 El-Komy M, Amin I, El-Hawary MS, Saadi D, Shaker O. Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17. Int J Immunopathol Pharmacol 2020;34:2058738420933742. [PMID: 32602388 DOI: 10.1177/2058738420933742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Kellermayer R. Epigenetics and the developmental origins of inflammatory bowel diseases. Can J Gastroenterol 2012;26:909-15. [PMID: 23248794 DOI: 10.1155/2012/526408] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
53 Xu J, Xu H, Yang M, Liang Y, Peng Q, Zhang Y, Tian C, Wang L, Yao J, Nie Y, Li D. New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease. Front Pharmacol 2022;13:813659. [DOI: 10.3389/fphar.2022.813659] [Reference Citation Analysis]
54 Clemente E, Efthymakis K, Carletti E, Capone V, Sperduti S, Bologna G, Marchisio M, Di Nicola M, Neri M, Sallese M. An explorative study identifies miRNA signatures for the diagnosis of non-celiac wheat sensitivity. PLoS One 2019;14:e0226478. [PMID: 31834915 DOI: 10.1371/journal.pone.0226478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
55 Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, Nielsen OH. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol 2013; 19(27): 4289-4299 [PMID: 23885139 DOI: 10.3748/wjg.v19.i27.4289] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
56 Stachurska A, Zorro MM, van der Sijde MR, Withoff S. Small and Long Regulatory RNAs in the Immune System and Immune Diseases. Front Immunol 2014;5:513. [PMID: 25368617 DOI: 10.3389/fimmu.2014.00513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
57 Goldschmidt I, Thum T, Baumann U. Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease. J Clin Med 2016;5:E28. [PMID: 26927196 DOI: 10.3390/jcm5030028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
58 Williams MR, Stedtfeld RD, Tiedje JM, Hashsham SA. MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome. Front Microbiol 2017;8:1896. [PMID: 29021788 DOI: 10.3389/fmicb.2017.01896] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
59 Ranjha R, Paul J. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer. Inflamm Res. 2013;62:343-355. [PMID: 23417288 DOI: 10.1007/s00011-013-0600-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
60 Moret-Tatay I, Iborra M, Cerrillo E, Tortosa L, Nos P, Beltrán B. Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel. Oxid Med Cell Longev 2016;2016:2325162. [PMID: 26823944 DOI: 10.1155/2016/2325162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
61 Chapman CG, Pekow J. The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol. 2015;8:4-22. [PMID: 25553076 DOI: 10.1177/1756283x14547360] [Cited by in Crossref: 99] [Cited by in F6Publishing: 55] [Article Influence: 14.1] [Reference Citation Analysis]
62 Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C. Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease. Metab Brain Dis 2021. [PMID: 33881722 DOI: 10.1007/s11011-021-00735-2] [Reference Citation Analysis]
63 Hübenthal M, Hemmrich-Stanisak G, Degenhardt F, Szymczak S, Du Z, Elsharawy A, Keller A, Schreiber S, Franke A. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease. PLoS One. 2015;10:e0140155. [PMID: 26466382 DOI: 10.1371/journal.pone.0140155] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
64 Schaefer JS. MicroRNAs: how many in inflammatory bowel disease? Curr Opin Gastroenterol. 2016;32:258-266. [PMID: 27138057 DOI: 10.1097/mog.0000000000000284] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
65 Lu TX, Sherrill JD, Wen T, Plassard AJ, Besse JA, Abonia JP, Franciosi JP, Putnam PE, Eby M, Martin LJ, Aronow BJ, Rothenberg ME. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol 2012;129:1064-75.e9. [PMID: 22391115 DOI: 10.1016/j.jaci.2012.01.060] [Cited by in Crossref: 95] [Cited by in F6Publishing: 103] [Article Influence: 9.5] [Reference Citation Analysis]
66 Russo F, Di Bella S, Nigita G, Macca V, Laganà A, Giugno R, Pulvirenti A, Ferro A. miRandola: extracellular circulating microRNAs database. PLoS One 2012;7:e47786. [PMID: 23094086 DOI: 10.1371/journal.pone.0047786] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 11.6] [Reference Citation Analysis]
67 Li J, Panganiban R, Kho AT, McGeachie MJ, Farnam L, Chase RP, Weiss ST, Lu Q, Tantisira KG. Circulating MicroRNAs and Treatment Response in Childhood Asthma. Am J Respir Crit Care Med 2020;202:65-72. [PMID: 32272022 DOI: 10.1164/rccm.201907-1454OC] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
68 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
69 Kubiritova Z, Radvanszky J, Gardlik R. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E3662. [PMID: 31357438 DOI: 10.3390/ijms20153662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
70 Mi S, Zhang J, Zhang W, Huang RS. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna 2013;2:63-71. [PMID: 25019052 DOI: 10.2174/2211536611302010007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
71 Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50 [PMID: 26855811 DOI: 10.4292/wjgpt.v7.i1.41] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]